IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $498,000 | -5.3% | 11,265 | -20.8% | 0.02% | +18.8% |
Q2 2022 | $526,000 | +28.9% | 14,216 | +29.0% | 0.02% | +60.0% |
Q1 2022 | $408,000 | +6.0% | 11,022 | -12.9% | 0.01% | +25.0% |
Q4 2021 | $385,000 | -9.0% | 12,651 | +0.4% | 0.01% | -11.1% |
Q3 2021 | $423,000 | -19.4% | 12,603 | -4.3% | 0.01% | -10.0% |
Q2 2021 | $525,000 | -74.7% | 13,169 | -71.5% | 0.01% | -75.6% |
Q1 2021 | $2,074,000 | +192.5% | 46,133 | +268.0% | 0.04% | +173.3% |
Q4 2020 | $709,000 | +60.4% | 12,536 | +34.5% | 0.02% | +50.0% |
Q3 2020 | $442,000 | -19.5% | 9,319 | 0.0% | 0.01% | -28.6% |
Q2 2020 | $549,000 | -15.8% | 9,319 | -32.4% | 0.01% | -22.2% |
Q1 2020 | $652,000 | -22.5% | 13,795 | -0.9% | 0.02% | 0.0% |
Q4 2019 | $841,000 | -16.7% | 13,922 | -17.4% | 0.02% | -21.7% |
Q3 2019 | $1,009,000 | -7.2% | 16,846 | -0.4% | 0.02% | -4.2% |
Q2 2019 | $1,087,000 | -5.1% | 16,920 | +19.9% | 0.02% | -4.0% |
Q1 2019 | $1,145,000 | +50.1% | 14,112 | 0.0% | 0.02% | +31.6% |
Q4 2018 | $763,000 | -3.4% | 14,112 | -7.8% | 0.02% | +18.8% |
Q3 2018 | $790,000 | +23.8% | 15,312 | 0.0% | 0.02% | +23.1% |
Q2 2018 | $638,000 | -10.3% | 15,312 | -5.1% | 0.01% | -7.1% |
Q1 2018 | $711,000 | +746.4% | 16,131 | +602.6% | 0.01% | +600.0% |
Q3 2016 | $84,000 | -34.4% | 2,296 | -58.4% | 0.00% | -33.3% |
Q2 2016 | $128,000 | -48.4% | 5,515 | -10.1% | 0.00% | -50.0% |
Q1 2016 | $248,000 | -34.7% | 6,133 | 0.0% | 0.01% | -33.3% |
Q4 2015 | $380,000 | – | 6,133 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |